Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Raw Materials: 2022-2025

Historic Raw Materials for InMed Pharmaceuticals (INM) over the last 4 years, with Jun 2025 value amounting to $258,300.

  • InMed Pharmaceuticals' Raw Materials fell 37.26% to $172,200 in Q3 2025 from the same period last year, while for Sep 2025 it was $172,200, marking a year-over-year decrease of 37.26%. This contributed to the annual value of $258,300 for FY2025, which is 30.69% down from last year.
  • InMed Pharmaceuticals' Raw Materials amounted to $258,300 in FY2025, which was down 30.69% from $372,695 recorded in FY2024.
  • InMed Pharmaceuticals' Raw Materials' 5-year high stood at $372,695 during FY2024, with a 5-year trough of $208,737 in FY2023.
  • Over the past 3 years, InMed Pharmaceuticals' median Raw Materials value was $258,300 (recorded in 2025), while the average stood at $279,911.
  • Its Raw Materials has fluctuated over the past 5 years, first soared by 78.55% in 2024, then crashed by 30.69% in 2025.
  • InMed Pharmaceuticals' Raw Materials (Yearly) stood at $292,577 in 2022, then dropped by 28.66% to $208,737 in 2023, then surged by 78.55% to $372,695 in 2024, then tumbled by 30.69% to $258,300 in 2025.